rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Veru Inc.

VERU · Nasdaq

Health CareBiotechnologyNot moving yet

VERU stood above a rising 150-day average in 7 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 8.3% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 3
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$9,684
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
58 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$81KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
K. Gary BarnetteChief Scientific Officerbought1,800at $2.6913 Aug 2026filed 17 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders58+4 on the quarter
New · exited14 · 10
Reported value$8.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026698,439$2.2M+159,057+29.5%
Alyeska Investment Group, L.P.reduced · filed 14 Aug 2026238,556$747K-761,444−76.1%
OPPENHEIMER & CO INCadded · filed 3 Aug 2026210,843$660K+14,543+7.4%
BlackRock, Inc.added · filed 7 Aug 2026167,084$523K+52,915+46.3%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026164,450$515K+95,200+137.5%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026155,076$486K-29,546−16.0%
Summit Financial, LLCreduced · filed 12 Aug 2026141,865$444K-9,918−6.5%
JANE STREET GROUP, LLCadded · filed 14 Aug 2026127,853$400K+105,046+460.6%
RAYMOND JAMES FINANCIAL INCadded · filed 14 Aug 202684,969$266K+17,408+25.8%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202681,230$254K+577+0.7%
30 Sep 2025 – 30 Jun 2026
495459Sep 25Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

K. Gary Barnette Company insiderChief Scientific Officer · last 13 Aug 20264 · 1
Grace Hyun Company insiderDirector · last 4 May 20261 · 0
Harry Fisch Company insiderChief Corporate Officer · last 4 May 202635 · 1
Loren Mark Katzovitz Company insiderDirector · last 4 May 20260 · 0
Lucy Lu Company insiderDirector · last 4 May 20262 · 0
Michael L. Rankowitz Company insiderDirector · last 4 May 20262 · 0
Michele Greco Company insiderChief Admin Officer and CFO · last 4 May 20264 · 0
Mitchell Shuster Steiner Company insiderPresident and CEO · last 4 May 202612 · 39
Mario Eisenberger Company insiderDirector · last 1 Oct 20240 · 1
Jesus Socorro Company insiderDirector · last 13 Nov 20205 · 0
Charles T. Todd, Jr. Company insiderCEO of FHC Division · last 2 Jan 20190 · 0
David R. Bethune Company insiderDirector · last 31 Oct 201810 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 30 Sep 2025-112%
Share count trendFY 2025 · to 12 Dec 20259.6%
Cash and equivalentsFY 2025 · to 30 Sep 2025$15.8M
Free cash flowFY 2025 · to 30 Sep 2025−$30.0M

Analyst forecasts

No analyst forecasts yet.